Navigation Links
MDS Responds to AECL and Government of Canada Announcements Regarding Maple Project
Date:5/16/2008

TORONTO, May 16 /PRNewswire-FirstCall/ - Earlier this morning, Atomic Energy of Canada Ltd. (AECL) announced it would discontinue the development of the MAPLE reactors at Chalk River, but remains committed to providing ongoing supply of medical isotopes.

MDS Inc., a leading provider of products and services to the global life sciences markets, was not consulted by AECL about this decision, and the company is evaluating these developments. MDS Nordion, a business unit of MDS, is a leading provider of medical isotopes and radiopharmaceuticals.

"The most important issue has always been the continuity of medical isotope supply for patients worldwide," said Stephen P. DeFalco, President and CEO, MDS Inc. "We are pleased that the government has asked AECL to pursue the extension of the NRU operation beyond its current license and to ensure the ongoing supply of these critical medical isotopes."

MDS is disappointed that AECL has stated it will not complete the MAPLE project despite significant investment and effort over the past 12 years. The company will evaluate all options and pursue appropriate steps to protect the interests of patients, its customers and its shareholders.

About MDS

MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and the diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 5,500 highly skilled people in 29 countries. Find out more at http://www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.


'/>"/>
SOURCE MDS Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Undeterred Despite the Obstacles: American Refugee Committee Responds to Tragedy in Myanmar
2. Aid Urgently Needed in Myanmar (Burma): Lutheran World Relief Responds
3. Neuralstem Responds to Incorrect StemCells, Inc. Release on Patents
4. Terumo Cardiovascular Systems Responds to Allegations of Patent Infringement
5. The Toy Industry Association Responds to Washington State Law Governing the Sale of Toys and the Governors Veto of Key Sections of the Bill
6. Biotest Pharmaceuticals Corporation Responds to Orphan Drug Act Announcement
7. DRAXIS Responds to Trading
8. Maternal love: How a mothers brain responds to her infant
9. DuPont Responds to Spelter, W.Va. Lawsuit Rulings
10. Blue Cross of California Responds to Recent Media Coverage of Rescission
11. Veterans for Americas (VFA) Wounded Warrior Outreach Program Responds to Fort Drum in Aftermath of Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... City, NY (PRWEB) , ... March 29, 2017 ... ... for men’s and women’s professional squash, announced it has enlisted New York City-based ... The agency will develop and procure sponsorship opportunities for the Professional Squash ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its ... Life" or "Wonder Spice", it has been used for thousands of years. , "The ... says Heshelow, author of " Turmeric: How to Use it For Your Wellness. Overcome ...
(Date:3/29/2017)... Indianapolis, IN (PRWEB) , ... March 29, 2017 ... ... Benefits Study, this webinar provides insight into the challenges employers face in trying ... the complexity of managing employee benefits programs? Adding to the growing complexity, ...
(Date:3/29/2017)... Illinois (PRWEB) , ... March 29, 2017 , ... ... Stencils Device Library for documenting and diagramming network and data center assets and ... , NetZoom subscribers can request new equipment shapes for free and download shapes ...
(Date:3/29/2017)... Yorba Linda, Ca (PRWEB) , ... March 29, 2017 , ... ... treatment of a growing number of cancers and is touted to be the next ... of treatment, thus far, has been in the form of immune checkpoint inhibitors such ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017  BioSpecifics Technologies Corp. (NASDAQ: BSTC), ... develop collagenase based-therapies with a first in class ... XIAFLEX ®  in the U.S. and Xiapex ® ... corporate overview at the upcoming 16 th ... 2017 at 8:00 a.m. ET in ...
(Date:3/29/2017)... , March 29, 2017 Today, CVS Health ... Kim Reynolds , Department of Public Health Director ... Steve Lukan in announcing the availability of the ... Pharmacy locations in Iowa.  CVS Health has established a standing ... allows CVS Pharmacy to expand access to the medication in ...
(Date:3/29/2017)... 2017  The Global Health Innovative Technology Fund ... to battle infectious diseases around the globe, today ... could help deliver a range of new innovative ... This latest round of targeted support ... testing a pediatric formulation of a drug considered ...
Breaking Medicine Technology: